OABIW OmniAb, Inc.

Nasdaq Services-Commercial Physical & Biological Research DE CIK: 0001846253
AI RATING
STRONG_SELL
85% Confidence

Investment Thesis

OmniAb is burning cash at an unsustainable rate (-$36.5M operating CF) while revenue contracts 29.3% YoY, generating massive operating losses (-369.5% margin). Despite a fortress balance sheet, the company's core business model is fundamentally broken with negative cash flow and deteriorating top-line growth indicating imminent financial distress.

Strengths

  • + Strong balance sheet with zero long-term debt (Debt/Equity 0.00x)
  • + Excellent liquidity position with 4.02x current ratio and $25.5M cash
  • + Substantial stockholders' equity of $267.0M provides solvency buffer

Risks

  • ! Revenue declining 29.3% YoY with only $18.7M top-line
  • ! Operating cash flow negative at -$36.5M indicating business is destroying value
  • ! Extreme operating margin of -369.5% and net margin of -347.0% unsustainable
  • ! At current burn rate, cash runway limited to <9 months
  • ! Operating losses of $69.0M dwarf revenue, suggesting fundamental business model failure

Key Metrics to Watch

Financial Metrics

Revenue
18.7M
Net Income
-64.8M
EPS (Diluted)
$-0.57
Free Cash Flow
-37.0M
Total Assets
300.9M
Cash
25.5M

Profitability Ratios

Gross Margin N/A
Operating Margin -369.5%
Net Margin -347.0%
ROE -24.3%
ROA -21.5%
FCF Margin -198.3%

Balance Sheet & Liquidity

Current Ratio
4.02x
Quick Ratio
3.97x
Debt/Equity
0.00x
Debt/Assets
11.3%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-13T11:21:19.792048 | Data as of: 2025-12-31 | Powered by Claude AI